<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lau HHC</submitter><funding>NIA NIH HHS</funding><funding>Parkinson Society Canada</funding><funding>National Institute on Aging</funding><funding>Canadian Institutes of Health Research</funding><pagination>72</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10155462</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Unique strains of α-synuclein aggregates have been postulated to underlie the spectrum of clinical and pathological presentations seen across the synucleinopathies. Whereas multiple system atrophy (MSA) is associated with a predominance of oligodendroglial α-synuclein inclusions, α-synuclein aggregates in Parkinson's disease (PD) preferentially accumulate in neurons. The G51D mutation in the SNCA gene encoding α-synuclein causes an aggressive, early-onset form of PD that exhibits clinical and neuropathological traits reminiscent of both PD and MSA. To assess the strain characteristics of G51D PD α-synuclein aggregates, we performed propagation studies in M83 transgenic mice by intracerebrally inoculating patient brain extracts. The properties of the induced α-synuclein aggregates in the br</pubmed_abstract><journal>Acta neuropathologica communications</journal><pubmed_title>The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.</pubmed_title><pmcid>PMC10155462</pmcid><funding_grant_id>2016-924</funding_grant_id><funding_grant_id>P30AG062421</funding_grant_id><funding_grant_id>PJT-169042</funding_grant_id><pubmed_authors>Lau HHC</pubmed_authors><pubmed_authors>Stuart E</pubmed_authors><pubmed_authors>Mao A</pubmed_authors><pubmed_authors>Hyman BT</pubmed_authors><pubmed_authors>Mehra S</pubmed_authors><pubmed_authors>Martinez-Valbuena I</pubmed_authors><pubmed_authors>Schmitt-Ulms C</pubmed_authors><pubmed_authors>Watts JC</pubmed_authors><pubmed_authors>So RWL</pubmed_authors><pubmed_authors>Kovacs GG</pubmed_authors><pubmed_authors>Ingelsson M</pubmed_authors><pubmed_authors>Silver NRG</pubmed_authors></additional><is_claimable>false</is_claimable><name>The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.</name><description>Unique strains of α-synuclein aggregates have been postulated to underlie the spectrum of clinical and pathological presentations seen across the synucleinopathies. Whereas multiple system atrophy (MSA) is associated with a predominance of oligodendroglial α-synuclein inclusions, α-synuclein aggregates in Parkinson's disease (PD) preferentially accumulate in neurons. The G51D mutation in the SNCA gene encoding α-synuclein causes an aggressive, early-onset form of PD that exhibits clinical and neuropathological traits reminiscent of both PD and MSA. To assess the strain characteristics of G51D PD α-synuclein aggregates, we performed propagation studies in M83 transgenic mice by intracerebrally inoculating patient brain extracts. The properties of the induced α-synuclein aggregates in the br</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-22T04:09:27.229Z</modification><creation>2025-04-05T20:52:58.146Z</creation></dates><accession>S-EPMC10155462</accession><cross_references><pubmed>37138318</pubmed><doi>10.1186/s40478-023-01570-5</doi></cross_references></HashMap>